INTERNATIONAL PATENT: ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. FILES APPLICATION FOR "T CELL RECEPTOR SPECIFIC TO KMT2A::AFF1 NEOANTIGEN AND USE THEREOF IN ADOPTIVE IMMUNOTHERAPY"

GENEVA, June 19 -- ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (262 Danny Thomas PlaceMemphis, Tennessee 38105) filed a patent application (PCT/US2024/058390) for "T CELL RECEPTOR SPECIFIC TO KMT2A::AFF1 NEOANTIGEN AND USE THEREOF IN ADOPTIVE IMMUNOTHERAPY" on Dec 04, 2024. With publication no. WO/2025/122569, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): THOMAS, Paul G. (c/o St. Jude Children's Research Hospital, Inc.262 Danny Thomas PlaceMemphis, Tennessee 38105), TIRTAKUSUMA, Ricky (c/o St. Jude Children's Research H...